AVXL — ANAVEX LIFE SCIENCES CORP
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
About ANAVEX LIFE SCIENCES CORP (AVXL)
ANAVEX LIFE SCIENCES CORP (AVXL) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $6M. Across recent filings, tracked investors recorded 4 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in AVXL
How many top investors track AVXL
A small number of top investors own this.
AVXL Ownership Composition
How ANAVEX LIFE SCIENCES CORP is held across tracked investor types, based on reported 13F positions.
- Other79.0%
- Hedge Funds21.0%
Tracked investors reporting AVXL
- Ken GriffinMar 31, 2026Citadel AdvisorsShares1.2MValue$3.6M% Portfolio0.00%
- Steve CohenDec 31, 2025Point72 Asset ManagementShares278KValue$989.7K% Portfolio0.00%
- Paul Tudor JonesMar 31, 2026Tudor Investment CorpShares42.7KValue$131.1K% Portfolio0.00%
Recent activity
- $131.1KMay 15, 2026
- New$989.7KFeb 17, 2026
- New$3.6MMay 15, 2026
- New$5.9MNov 14, 2025
Frequently asked questions
- How many institutional investors hold AVXL?
- 3 tracked institutional investors disclosed a position in AVXL (ANAVEX LIFE SCIENCES CORP) in their most recent 13F filing.
- Who is the largest institutional holder of AVXL?
- Ken Griffin, Citadel Advisors, holds the largest disclosed position in AVXL, valued at $6M.
- Did institutional ownership of AVXL increase or decrease?
- Across recent 13F filings, tracked investors recorded 4 new positions, 0 increased, 0 reduced, and 0 fully exited AVXL.
- Where does this AVXL ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.